Open-access Effect of trolox C on cardiac contracture induced by hydrogen peroxide

Abstract

Hydrogen peroxide (H2O2) perfused into the aorta of the isolated rat heart induces a positive inotropic effect, with cardiac arrhythmia such as extrasystolic potentiation or cardiac contractures, depending on the dose. The last effect is similar to the "stone heart" observed in reperfusion injury and may be ascribed to lipoperoxidation (LPO) of the membrane lipids, to protein damage, to reduction of the ATP level, to enzymatic alterations and to cardioactive compounds liberated by LPO. These effects may result in calcium overload of the cardiac fibers and contracture ("stone heart"). Hearts from male Wistar rats (300-350 g) were perfused at 31oC with Tyrode, 0.2 mM trolox C, 256 mM H2O2 or trolox C + H2O2. Cardiac contractures (baseline elevation of the myograms obtained) were observed when hearts were perfused with H2O2 (Tyrode: 5.9 ± 3.2; H2O2: 60.5 ± 13.9% of the initial value); perfusion with H2O2 increased the LPO of rat heart homogenates measured by chemiluminescence (Tyrode: 3,199 ± 259; H2O2: 5,304 ± 133 cps mg protein-1 60 min-1), oxygen uptake (Tyrode: 0.44 ± 0.1; H2O2: 3.2 ± 0.8 nmol min-1 mg protein-1) and malonaldehyde (TBARS) formation (Tyrode: 0.12 ± 0; H2O2: 0.37 ± 0.1 nmol/ml). Previous perfusion with 0.2 mM trolox C reduced the LPO (chemiluminescence: 4,098 ± 531), oxygen uptake (0.51 ± 0) and TBARS (0.13 ± 0) but did not prevent the H2O2-induced contractures (33.3 ± 16%). ATP (Tyrode: 2.84 ± 0; H2O2: 0.57 ± 0) and glycogen levels (Tyrode: 0.46 ± 0; H2O2: 0.26 ± 0) were reduced by H2O2. Trolox did not prevent these effects (ATP: 0.84 ± 0 and glycogen: 0.27 ± 0). Trolox C is known to be more effective than <!-- $MVD$:face("Symbol") --><FONT FACE="Symbol">a</font> -tocopherol or <!-- $MVD$:face("Symbol") --><FONT FACE="Symbol">g</font> -tocopherol in reducing LPO though it lacks the phytol portion of vitamin E to be fixed to the cell membranes. Trolox C, unlike vitamin A, did not prevent the glycogen reduction induced by H2O2. Trolox C induced a positive chronotropic effect that resulted in higher energy consumption. The reduction of energy level seemed to be more important than LPO in the mechanism of H2O2-induced contracture

trolox C; "stone heart"; free radicals; hydrogen peroxide


Braz J Med Biol Res, November 1997, Volume 30(11) 1337-1342

1Laboratório de Fisiologia Cardiovascular, Departamento de Fisiologia, Instituto de Biociências, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil

2Departamento de Quimica Analitica y Fisicoquimica, FFB, Universidad de Buenos Aires, Buenos Aires, Argentina

References

Correspondence and Footnotes Correspondence and Footnotes Correspondence and Footnotes

Abstract

Hydrogen peroxide (H2O2) perfused into the aorta of the isolated rat heart induces a positive inotropic effect, with cardiac arrhythmia such as extrasystolic potentiation or cardiac contractures, depending on the dose. The last effect is similar to the "stone heart" observed in reperfusion injury and may be ascribed to lipoperoxidation (LPO) of the membrane lipids, to protein damage, to reduction of the ATP level, to enzymatic alterations and to cardioactive compounds liberated by LPO. These effects may result in calcium overload of the cardiac fibers and contracture ("stone heart"). Hearts from male Wistar rats (300-350 g) were perfused at 31oC with Tyrode, 0.2 mM trolox C, 256 mM H2O2 or trolox C + H2O2. Cardiac contractures (baseline elevation of the myograms obtained) were observed when hearts were perfused with H2O2 (Tyrode: 5.9 ± 3.2; H2O2: 60.5 ± 13.9% of the initial value); perfusion with H2O2 increased the LPO of rat heart homogenates measured by chemiluminescence (Tyrode: 3,199 ± 259; H2O2: 5,304 ± 133 cps mg protein-1 60 min-1), oxygen uptake (Tyrode: 0.44 ± 0.1; H2O2: 3.2 ± 0.8 nmol min-1 mg protein-1) and malonaldehyde (TBARS) formation (Tyrode: 0.12 ± 0; H2O2: 0.37 ± 0.1 nmol/ml). Previous perfusion with 0.2 mM trolox C reduced the LPO (chemiluminescence: 4,098 ± 531), oxygen uptake (0.51 ± 0) and TBARS (0.13 ± 0) but did not prevent the H2O2-induced contractures (33.3 ± 16%). ATP (Tyrode: 2.84 ± 0; H2O2: 0.57 ± 0) and glycogen levels (Tyrode: 0.46 ± 0; H2O2: 0.26 ± 0) were reduced by H2O2. Trolox did not prevent these effects (ATP: 0.84 ± 0 and glycogen: 0.27 ± 0). Trolox C is known to be more effective than a-tocopherol or g-tocopherol in reducing LPO though it lacks the phytol portion of vitamin E to be fixed to the cell membranes. Trolox C, unlike vitamin A, did not prevent the glycogen reduction induced by H2O2. Trolox C induced a positive chronotropic effect that resulted in higher energy consumption. The reduction of energy level seemed to be more important than LPO in the mechanism of H2O2-induced contracture.

Key words: trolox C, "stone heart", free radicals, hydrogen peroxide

Introduction

Bianchini and Belló (1) demonstrated a positive inotropic effect with cardiac arrhythmia induced by hydrogen peroxide (H2O2) by using whole perfused rat hearts. The injection of 0.15 ml of 128 mM H2O2 into the aorta of the isolated rat heart (perfused at constant pressure) induces cardiac contracture ("stone heart") (2) that is partially antagonized by nifedipine (3) or more efficiently by 0.1 mM indomethacin (4).

The mechanisms that seem to be responsible for these cardiac effects may be attributed to lipoperoxidation (LPO) of membrane lipids (5), to protein damage, to reduction of the ATP level induced by H2O2, to enzymatic alterations (6) and to cardioactive compounds such as prostaglandins and leukotrienes liberated by LPO (4). These mechanisms may result in cytoplasmic calcium overload inducing cardiac contracture.

During the LPO process there is singlet oxygen formation that accelerates this oxidation, thus increasing the changes in membrane permeability.

Tocopherols are considered to be singlet oxygen quenchers (7,8). Trolox C, the polar portion of vitamin E, is water soluble and is reported to be more active than a- and g-tocopherols and may interfere with the chain reaction of lipid peroxidation by reacting directly with peroxyl and alkoxyl radicals (9).

The aim of the present study was to test the hypothesis that trolox C can protect the rat heart from the oxidative stress induced by hydrogen peroxide.

Material and Methods

Male Wistar rats (300-350 g) were obtained from the Central Animal House of the Universidade Federal do Rio Grande do Sul. The animals were housed in plastic cages (47 x 34 x 18 cm, three animals per cage) lined with sawdust changed every 48 h, in air-conditioned quarters and had free access to tap water and pelleted food (Purina, Nutripal, Porto Alegre, RS, Brazil).

Animals were killed by a blow to the head and the chest was opened. The heart was carefully dissected from its connections and the aorta retroperfused with Tyrode solution of the following composition: 120 mM NaCl, 5.4 mM KCl, 1.8 mM MgCl2, 1.25 mM CaCl2, 27 mM NaHCO3, 2.0 mM NaH2PO4, 1.8 mM Na2SO4 and 11.1 mM glucose, pH = 7.4. This solution was maintained at 31oC, gassed with O2:CO2 (95%/5%) and used for perfusion at a constant pressure of 8.02 kPa.

Four groups (six hearts each) were studied: a) control: hearts perfused with Tyrode for 30 min; b) trolox: hearts perfused with Tyrode for 10 min and with Tyrode plus trolox C (0.2 mM; Aldrich Chemical Company, Milwaukee, WI) for another 20 min; c) H2O2: hearts perfused with Tyrode for 10 min and with Tyrode plus 256 mM H2O2 (Perhidrol, Merck, Darmstadt, Germany) for another 20 min; d) trolox and H2O2: hearts perfused with Tyrode plus trolox C (0.2 mM) for 10 min and Tyrode plus H2O2 (256 mM) for another 20 min.

The hydrogen peroxide dose was selected according to a previously established dose-concentration curve (2). The trolox dose employed was the same as used by Wu et al. (10).

In order to record the heart beats, the apex of the left ventricle was attached to a microdisplacement myograph transducer by means of a heart clip. Using a lifter, the load was increased until the heart worked at the Lmax level. The coronary flow (drops/min) was recorded using a piezoelectric drop counter. The results obtained during the last minute of the experiment are reported as percent of the values obtained over a period of 1 min measured between the 9th and 10th min after the beginning of perfusion.

The contractile force (g) from each heart was determined by measuring the amplitude of the myograms obtained at 10 min of perfusion (just before change of the perfusion fluid), and 20 min later. Contracture was considered to occur when the relaxation phase was significantly reduced and was determined by measuring the baseline elevation of the myograms and reported as percent of the value measured at 10 min of perfusion. Heart rate was measured from the myograms and the values obtained in the last minute of the experiment are reported as percent variation of the values obtained between the 9th and 10th minute of perfusion.

The transducers were attached to a recorder. All recording devices were from Narco Bio-System (Houston, Texas).

At the end of the experiments, a slice (±200 mg) obtained from the left ventricle was used for glycogen determination according to the method of Van Handel (11). Each remaining heart was then homogenized in an ultra-Turrax blender using 1 g of tissue in 5 ml 140 mmol/l potassium chloride containing 20 mmol/l phosphate buffer, pH = 7.4. The protein of the homogenate was measured by the method of Lowry et al. (12). The suspension (approximately 1 mg of protein/ml) was added to 3 mmol/l tert-butyl hydroperoxide (Sigma Chemical Company, St. Louis, MO) and assayed for chemiluminescence (13) in an LKB Rack Beta liquid scintillation spectrometer model 1215 (LKB-Produkter AB, Bromma, Sweden). Chemiluminescence is reported as counts per second per mg protein of the homogenate.

Aliquots were used for malonaldehyde determination according to the technique of Buege and Aust (14) for thiobarbituric acid reactive substances (TBARS).

Aliquots were also used for oxygen uptake determination (nmol min-1 mg protein-1) using an oxymeter with a Clark electrode purchased from FQ/IQUIFIB/MADEIC, Buenos Aires, Argentina.

In order to determine the adenosine-5'-triphosphate (ATP) level, the hearts of 16 rats (300-350 g) were perfused (N = 4 per group) in the same manner as the groups previously reported with Tyrode, 0.2 mM trolox C, 256 mM H2O2 and trolox C followed by H2O2. After perfusion, the hearts were homogenized and used for enzymatic determination of ATP (Sigma Diagnostics), according to Adams (15).

Results are reported as means ± SEM. Statistical evaluation was performed by two-way ANOVA followed by the Scheffé t-test or the Student t-test for independent samples using the SPSS-PC software (SPSS, Inc., Chicago, IL). P<0.05 was taken to be significant.

Results

Figure 1 shows typical myograms obtained from hearts perfused with the different solutions. Perfusion with H2O2 induced cardiac contractures, i.e., a 60% decrease in the relaxation phase with respect to the myograms observed at 10 min of perfusion (60.5 ± 13.9). Previous perfusion with 0.2 mM trolox C did not significantly reduce the contracture induced by H2O2 (33.3 ± 16.1) (Fcal = 1.64). A small nonsignificant increase in the relaxation phase was demonstrable when hearts were perfused only with 0.2 mM trolox C. The experiments were repeated with perfusion with 2 mM trolox C but the results were almost the same, i.e., trolox C did not block the cardiac contractures induced by H2O2 (data not shown).

Figure 2 shows the kinetic profile (77 min) of chemiluminescence initiated by tert-butyl hydroperoxide in homogenates of hearts perfused with 0.2 mM trolox C, 256 mM H2O2 and trolox C followed by H2O2.

Table 1 shows the results obtained by various methods used to study LPO. H2O2 injection increased oxygen uptake, TBARS levels and chemiluminescence of heart homogenates. In the hearts previously perfused with 0.2 mM trolox C, all these phenomena were reduced, indicating LPO reduction.

Table 2 shows the contracture, heart rate and coronary flow (% of the initial values) of the different groups. It should be pointed out that trolox C increased the heart rate and coronary flow but did not prevent the contractures and the coronary constriction induced by H2O2.

H2O2 reduced the heart glycogen concentration and trolox C did not prevent this reduction (Table 3). The ATP level was reduced by H2O2 and previous perfusion with trolox C did not inhibit this effect (Table 3).

Figure 1
- Typical records obtained from hearts perfused with trolox C (0.2 mM) (a), H2O2 (256 mM) (b) and trolox C followed by H2O2 (c). The figures show myograms for the last minute of the control period followed by records obtained for 1 min after the time indicated by the arrows.

Figure 2
- Kinetic profile of chemiluminescence initiated by tert-butyl hydroperoxide (counts per second per mg protein) from homogenates of hearts perfused with trolox C (0.2 mM), with hydrogen peroxide (256 mM) or with trolox C followed by hydrogen peroxide.

Discussion

The H2O2 dose used to induce cardiac contractures in the present study was high, far above the possible concentration level that would be observed in the ischemia-reperfusion phenomenon. The low temperature used (31oC) could explain, in part, the high dose employed, but the most important fact is that perfusion was performed at constant pressure. H2O2 is so potent a coronary constrictor that it almost completely blocks coronary flow within the first 5 s. To avoid coronary constriction, hearts were perfused at a constant flow. In this condition, contractures similar to those obtained in this study could be induced by doses as low as 0.25 mM. This H2O2 concentration would occur in the ischemia-reperfusion injury (16).

H2O2 can react with iron ions resulting in hydroxyl radical formation. This radical can initiate the LPO of membrane lipids. The lipoperoxide production may change membrane permeability leading to the formation of hydrophilic "pores" (5).

The arachidonic acid present in cell membranes can be liberated by LPO and form various cardioactive compounds. In particular, it can be converted into prostaglandins or leukotrienes (17). Fatty acids or their oxidation products may act as ionophores. The energy loss and the presence of" pores" result in intracellular calcium overload that blocks muscle relaxation.

The overall results indicate that H2O2 induced LPO and cardiac contracture and that trolox C (0.2 or 2 mM) was effective in preventing the H2O2-induced LPO but not the contractures.

During LPO there is singlet oxygen formation that increases this oxidative process (7). Tocopherols and trolox C are known to be singlet oxygen quenchers capable of reacting with LPO products. In our observation, the reductions in oxygen uptake, TBARS levels and chemiluminescence all suggest that singlet oxygen and/or products of the LPO were quenched or scavenged by trolox C. However, the present study indicates that effective protection by trolox C against H2O2-induced lipid peroxidation is not associated per se with effective protection against H2O2-induced contracture.

Schraufstatter et al. (6) observed that H2O2 can activate a nuclear enzyme, poly (ADP-ribose) polymerase, that uses NAD as substrate. The activation reduces the level of ATP necessary for the ionic pumps. H2O2 can also inhibit glycolysis, reducing the ATP stores necessary to maintain the fundamental ionic difference between the two cell membrane sides. Moreover, we observed that glycogen and ATP levels were reduced by H2O2 and trolox C was unable to prevent this reduction. On the other hand, vitamin A was more effective in protecting the heart from the oxidative stress induced by H2O2, by reducing the contractures and LPO and by maintaining the glycogen level (Table 2) (18). The contracture was probably prevented by vitamin A by means of energy conservation.

H2O2, at the dose employed, provoked depression of the contractile function ("stunning"). Trolox C, unlike vitamin A, increased the heart rate (18). This may result in greater energy consumption, reducing the energy available for the ionic pumps, leading to an elevation of intracellular calcium. The increased intracellular calcium level (that may be responsible for the contracture) can activate calcium-dependent phospholipases with subsequent release of fatty acids from membranes and activation of the arachidonic acid cascade. It is known that cardiac contractures can be induced by prostaglandins (19). The calcium overload results in cardiac stiffening known as "stone heart" or cardiac contracture.

It can also be seen in Table 2 that trolox C increased coronary flow and heart rate, which in turn also increased energy consumption. The vasodilation induced by trolox C is a result that merits further investigation.

Trolox C does not have the phytol portion of vitamin E that fixes this vitamin to the cell membrane (20). This localization is strategic to protect the cell membrane against lesions induced by oxidative stress. But the reduction of the energy level seemed to be more important than LPO in the mechanism of cardiac H2O2-induced contractures.

Acknowledgments

We thank Tânia Regina Gattelli Fernandes for technical assistance.

Address for correspondence: A.A. Belló, Laboratório de Fisiologia Cardiovascular, Departamento de Fisiologia, Instituto de Biociências, UFRGS, Rua Sarmento Leite, 500, 90050-170 Porto Alegre, RS, Brasil. Fax: 55 (051) 316-3166. E-mail: bello@pro.via-rs.com.br

Research supported by FINEP, CAPES, CNPq, FAPERGS and PROPESP-UFRGS. Received July 15, 1996. Accepted August 18, 1997.

References

  • 1. Bianchini A & Belló AA (1988). Hydrogen peroxide effects on the contractile force and coronary flow of the rat isolated heart. Medical Science Research, 16: 1265-1266.
  • 2. Belló AR & Belló AA (1988). Cardiac contracture induced by hydrogen peroxide. Medical Science Research, 16: 1149-1150.
  • 3. Belló AR & Belló AA (1989). Effect of nifedipine on cardiac contracture induced by hydrogen peroxide. Medical Science Research, 17: 237-238.
  • 4. Belló AR & Belló AA (1989). Indomethacin antagonizes cardiac contracture induced by hydrogen peroxide. Medical Science Research, 17: 627-628.
  • 5. Blokha VV, Kagan VY, Sitkovskii MV, Danilov VS, Kols OR & Koslov YP (1972). Peroxidation of lipids and conduction of excitation in frog muscles. Biofizika, 17: 549-551.
  • 6. Schraufstatter IU, Hyslop PA, Hinshaw DB, Spaag RG, Sklar LA & Cochrane CG (1986). Hydrogen peroxide induced injury of cells and its prevention by inhibitors of poly (ADP-ribose) polymerase. Proceedings of the National Academy of Sciences, USA, 83: 4908-4912.
  • 7. Halliwell B & Gutteridge JMC (1989). Free Radicals in Biology and Medicine 2nd edn. Clarendon Press, Oxford.
  • 8. Kaiser S, Di Maschio P, Murphy M & Sies H (1990). Physical and chemical scavenging of singlet molecular oxygen by tocopherols. Archives of Biochemistry and Biophysics, 277: 101-108.
  • 9. Sies H & Murphy ME (1991). Role of tocopherols in the protection of biological systems against oxidative damage. Journal of Photochemistry and Photobiology. B, Biology, 8: 211-224.
  • 10. Wu TW, Hashimoto N, Au Jx, Wu J, Mickle DAG & Carey D (1991). Trolox protects rat hepatocytes against oxyradical damage and the ischemic rat liver from reperfusion injury. Hepatology, 13: 575-580.
  • 11. Van Handel E (1965). Estimation of glycogen in small soft tissue. Analytical Biochemistry, 11: 256-265.
  • 12. Lowry OH, Rosebrough NJ, Farr AL & Randall RJ (1951). Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193: 265-275.
  • 13. Llesuy SF, Milei J, Gonzalez-Flecha BS & Boveris A (1990). Myocardial damage induced by doxorubicin: hydroperoxide-initiated chemiluminescence and morphology. Free Radical Biology and Medicine, 8: 259-264.
  • 14. Buege JA & Aust SD (1978). Microsomal lipid peroxidation. Methods in Enzymology, 52: 302-309.
  • 15. Adams H (1963). Adenosine-5'-triphosphate determination with phosphoglycerate kinase. In: Bergmeyer H (Editor), Methods of Enzymatic Analysis Academic Press, New York, 539-543.
  • 16. Brunetto AF (1995). Efeitos mecânicos, lipoperoxidaçăo e entrada de Ca2+ induzidos por peróxido de hidrogęnio em miocárdio de rato. Doctoral thesis, Departamento de Fisiologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brasil.
  • 17. Basu DK & Karmazyn M (1987). Injury to rat hearts produced by an exogenous free radical generating system. Study into the role of arachidonic acid and eicosanoids. Journal of Pharmacology and Experimental Therapeutics, 242: 673-685.
  • 18. Belló-Klein A, Oliveira AR, Brunetto AF, Irigoyen MC, Llesuy S & Belló AA (1994). Effect of vitamin A on cardiac contracture induced by hydrogen peroxide. Medical Science Research, 22: 411-413.
  • 19. Karmazyn M, Leung CKH & Dhalla NS (1979). Prostaglandin actions and interactions on isolated perfused rat hearts. Canadian Journal of Physiology and Pharmacology, 57: 1275-1282.
  • 20. Massey KD & Burton KP (1989). Free radical damage in neonatal rat cardiac myocyte cultures: effects of alpha-tocopherols, trolox and phytol. American Journal of Physiology, 256: H1192-H1199.
  • Effect of trolox C on cardiac contracture induced by hydrogen peroxide
    A. Belló-Klein1, A.R. Oliveira1, M.F.S. Miranda1, M.C. Irigoyen1, P.I. Homem-de-Bittencourt Jr.1, S. Llesuy2 and A.A. Belló1
  • Correspondence and Footnotes
  • Publication Dates

    • Publication in this collection
      07 Oct 1998
    • Date of issue
      Nov 1997

    History

    • Accepted
      18 Aug 1997
    • Received
      15 July 1996
    location_on
    Associação Brasileira de Divulgação Científica Av. Bandeirantes, 3900, Cep: 14049-900 , Tel: +55 16 3630-2778, +55 16 3315-3173 - Ribeirão Preto - SP - Brazil
    E-mail: bjournal@terra.com.br
    rss_feed Acompanhe os números deste periódico no seu leitor de RSS
    Acessibilidade / Reportar erro